These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 19849752)
1. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. van Langenberg DR; Gearry RB; Wong HL; Ward M; Gibson PR Intern Med J; 2010 Dec; 40(12):819-27. PubMed ID: 19849752 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of faecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosing inflammatory and non-inflammatory diarrhoea in Dhaka, Bangladesh. Ashraf H; Beltinger J; Alam NH; Bardhan PK; Faruque AS; Akter J; Salam MA; Gyr N Digestion; 2007; 76(3-4):256-61. PubMed ID: 18196900 [TBL] [Abstract][Full Text] [Related]
3. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Vaishnavi C; Thapa BR; Thennarasu K; Singh K Indian J Pathol Microbiol; 2002 Jan; 45(1):69-73. PubMed ID: 12593568 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis. Vaishnavi C; Kochhar R; Bhasin D; Thennarasu K; Singh K Trop Gastroenterol; 2003; 24(1):13-6. PubMed ID: 12974208 [TBL] [Abstract][Full Text] [Related]
5. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital. Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443 [TBL] [Abstract][Full Text] [Related]
6. [Detection of lactoferrin in feces for differential diagnosis in diarrhea]. Fried K; Tárkányi K; Prinz G; Bán E Orv Hetil; 2002 Sep; 143(37):2141-4. PubMed ID: 12434630 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital. Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449 [TBL] [Abstract][Full Text] [Related]
9. Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea. Caccaro R; D'Incà R; Martinato M; Pont ED; Pathak S; Frigo AC; Sturniolo GC Biometals; 2014 Oct; 27(5):1069-76. PubMed ID: 24831229 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Schröder O; Naumann M; Shastri Y; Povse N; Stein J Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital]. Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153 [TBL] [Abstract][Full Text] [Related]
13. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Joshi S; Lewis SJ; Creanor S; Ayling RM Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914 [TBL] [Abstract][Full Text] [Related]
14. Faecal lactoferrin as a predictor of positive faecal culture in south Indian children with acute diarrhoea. Venkataraman S; Ramakrishna BS; Kang G; Rajan DP; Mathan VI Ann Trop Paediatr; 2003 Mar; 23(1):9-13. PubMed ID: 12648319 [TBL] [Abstract][Full Text] [Related]
15. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina]. Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). Chen LS; Liao CS; Chang SH; Lai HC; Chen TH J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564 [TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile-related disease: evaluation and prevalence among inpatients with diarrhea in two freestanding rehabilitation hospitals. Yablon SA; Krotenberg R; Fruhmann K Arch Phys Med Rehabil; 1993 Jan; 74(1):9-13. PubMed ID: 8267789 [TBL] [Abstract][Full Text] [Related]
18. C. difficile infection (CDI) in a long-term acute care facility (LTAC). Goldstein EJ; Polonsky J; Touzani M; Citron DM Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064 [TBL] [Abstract][Full Text] [Related]
19. Cost-effective screening of pooled faecal specimens from patients with nosocomial diarrhoea for Clostridium perfringens enterotoxin. Vaishnavi C; Singh G; Singh K Indian J Med Microbiol; 2011; 29(1):56-9. PubMed ID: 21304197 [TBL] [Abstract][Full Text] [Related]
20. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]